Investing Daily's investment experts share some intimate details about their investment firsts and what lessons they learned. Read More

Gilead Sciences (NasdaqGS: GILD) may lead the race to offer an all-oral treatment for Hepatitis C liver disease, but several other drug companies are also in the hunt. Read More

Taxes will increase, especially for investors, in 2013 and beyond. The only question is how high they will increase. Those in retirement or planning for retirement should expect to pay higher tax rates during their post-career years. You can act now to avoid the worst effects of the coming retiree tax attack.  Read More

Although an appeals court ruling granted coal companies a slight reprieve this week, the power industry’s inexorable shift toward cheap natural gas is likely to continue at least until the end of the decade, as the US lacks the necessary infrastructure to export its abundance of natural gas overseas. Read More

In the first installment of this two-part series, we explain why NGL prices will likely remain volatile in coming years. Next week's issue will focus on the extent to which fluctuations in the price of these commodities will impact the 17 publicly traded partnerships that own natural gas-processing assets. Read More

The stock market is near four-year highs, but that hasn't stopped some stocks from plunging. Jim discusses three such stocks, only one of which is a speculative buy. Read More

Although there are numerous investment products designed to exploit the VIX, their long-term price trajectory is toward zero. Read More

The Gap and American Eagle are running with the cool kids—while Aeropostale and Abercrombie & Fitch find themselves on the outside looking in. Read More

August means 13F filing season, which allows us to peek into the minds of the world's greatest investors. Consumer staples and technology are in, while Citigroup is out. Read More

If you are concerned about a market correction or worse, investing in companies that are influenced by women is a wise move. And you might outperform in bull markets, too! Read More